To Get Help Now
Click Here
 
Today's Date:

Medtronic is Paying the Authors of Controversial InFuse Research Millions of Dollars in Royalties Even as it Faces Thousands of Lawsuits

Medtronic is Paying Millions to the InFuse Research Authors

Medtronic is Paying Millions to the InFuse Research Authors


Medtronic continues to pay millions of dollars to doctors who authored questionable research articles concerning the safety and effectiveness of the company’s InFuse spine growth product.

In 2014, Medtronic Sofamor Danek – Medtronic’s spine division – paid $60.7 million in royalties to 79 doctors and their affiliates, including to the authors of controversial studies of InFuse. Dr. Ken Burkus, a Georgia surgeon and the lead author on six InFuse studies that omitted adverse events, received $374,000 from Medtronic. Dr. Regis Haid, an Atlanta, Georgia, neurosurgeon and the lead author of one study, was paid $2.3 million in royalties. Both doctors received their payments from third-party companies. StarTribune.com reports the company paid $90 million in royalties last year. More Medtronic is Paying the Authors of Controversial InFuse Research Millions of Dollars in Royalties Even as it Faces Thousands of Lawsuits

Maquet’s FLOW-i Anesthesia System Recalled Due to Potentially Fatal Ventilation Problem

Maquet's FLOW-i Anesthesia System Recalled

Maquet’s FLOW-i Anesthesia System Recalled


Some of Maquet’s FLOW-i Anesthesia Systems reportedly have a malfunction that could result in potentially fatal ventilation stops, the U.S. Food and Drug Administration (FDA) warned. A July 1st safety alert indicated that the issue “may cause anesthesia gas to leak and could prevent the ventilator from providing breathing support if not corrected immediately.”

The systems are used in hospitals to provide anesthesia and ventilation support in patients who have difficulty breathing. The recall, which affects 1,641 units worldwide including 80 in the United States, was initiated in April. The FDA labeled its as Class 1 in June, which means that there is a reasonable possibility of serious injury or death associated with the issue. More Maquet’s FLOW-i Anesthesia System Recalled Due to Potentially Fatal Ventilation Problem

Medtronic Unit Says It Will Settle Some of the 11,000 Transvaginal Mesh Lawsuits Facing the Company

Medtronic Will Settle 11,000 Transvaginal Mesh Lawsuits

Medtronic Will Settle 11,000 Transvaginal Mesh Lawsuits


Medtronic’s Covidien unit says it will settle some of the more than 11,000 transvaginal mesh lawsuits that have been filed on behalf of patients who allege the device caused them severe pain and serious side effects.

Covidien made the announcement Tuesday in a court filing in West Virginia federal court that was viewed by Reuters. Covidien said it could not disclose the amount of the settlement nor how many cases the confidential agreement with one of the plaintiffs’ law firms would resolve. More Medtronic Unit Says It Will Settle Some of the 11,000 Transvaginal Mesh Lawsuits Facing the Company

The Largest Food Vendor for the Washington D.C. Public School System Agrees to Pay $19 Million to Settle Whistleblower Lawsuit

D.C. Public Schoo  Food Vendor Agrees to Pay $19M

D.C. Public Schoo Food Vendor Agrees to Pay $19M


The largest food vendor for the public school system is Washington, D.C., has agreed to pay $19 million to settle a whistleblower lawsuit alleging that the company overcharged the district and mismanaged the school meals programs, with food often arriving at schools late, often spoiled or in short supply.

The whistleblower served as director of the D.C. Public School’s (DCPS) Office of Food and Nutritional Services from 2010 until he was fired in early 2013. The tipster filed a suit against Chartwells and Thompson Hospitality, two companies that formed a joint venture that provided food services for DCPS starting in 2008. The District’s attorney general issued a complaint and launched an investigation into the allegations, according to The Washington Post (The Post). More The Largest Food Vendor for the Washington D.C. Public School System Agrees to Pay $19 Million to Settle Whistleblower Lawsuit

Hundreds of Women Sue Johnson & Johnson over Use of Talcum Powder

Women Sue Johnson & Johnson over Use of Talcum Powder

Women Sue Johnson & Johnson over Use of Talcum Powder


The litigation against Johnson & Johnson over talcum powder continues to grow, as hundreds of women have filed a lawsuit alleging that the soft powder product caused ovarian cancer. The pharmaceutical giant was allegedly negligent with regards to the risks of their talcum powder products, such include Baby Powder and Shower to Shower. The women allege that J&J should have warned that use of talcum powder in the genital area could increase the risk of ovarian cancer.

FairWarning, a non-profit investigative news organization, reports that a number of studies link talcum powder to an increased risk of ovarian cancer. “Since the early 1980s, a slew of studies had found that women who regularly used talc powder for feminine hygiene had higher than average rates of ovarian cancer.” according to an article posted April 29th. More Hundreds of Women Sue Johnson & Johnson over Use of Talcum Powder

CVS Health Acknowledges Two of its Florida Pharmacies Sold Oxycodone for Illegitimate Purposes, Agrees to Pay Government $22 Million

CVS Acknowledges Two of its FL. Pharmacies Sold Oxycodone

CVS Acknowledges Two of its FL. Pharmacies Sold Oxycodone


CVS Health Corp will pay $22 million to settle a three-year federal investigation into whether two of the company’s pharmacies in central Florida sold oxycodone that was not prescribed for legitimate medical purposes.

The U.S. Drug Enforcement Agency (DEA) announced the deal Wednesday, officially bringing an end to the probe. According to a news release posted on the DEA’s website, Florida is the nation’s “epicenter” for the illegal distribution of prescription drugs. Prescription drug addicts were traveling to Florida to find doctors who would write prescriptions for oxycodone, a powerful and potentially addictive painkiller, as well as pharmacies that would fill the prescriptions, despite signs that they were illegitimate prescriptions. The investigation led to the DEA’s execution of administrative inspection warrants at the Sanford, Florida pharmacies. The government revoked the pharmacies’ licenses in June 2012. More CVS Health Acknowledges Two of its Florida Pharmacies Sold Oxycodone for Illegitimate Purposes, Agrees to Pay Government $22 Million

Tipster Wins 30 Percent of $2.2 Million Award After Former Employer Retaliates Against Him for Blowing the Whistle on Prohibited Principal Transactions

Tipster Wins 30 Percent of $2.2 Million Award

Tipster Wins 30 Percent of $2.2 Million Award


Companies that retaliate against whistleblowers may not only be penalized by the U.S. Securities and Exchange Commission (SEC), they may also distribute part of that penalty to the alleged victim of the retaliation.

The SEC did just that on Tuesday when the agency gave a former employee of Paradigm Capital Management Inc. a 30 percent cut of the penalty that his employer had to pay the federal government for allegedly retaliating against him, the first such action in the nation’s history, according to the Wall Street Journal (WSJ). More Tipster Wins 30 Percent of $2.2 Million Award After Former Employer Retaliates Against Him for Blowing the Whistle on Prohibited Principal Transactions

Takeda Announces $2.4 Billion Settlement in Actos Bladder Cancer Cases

Takeda Announces $2.4B Settlement in Actos Cases

Takeda Announces $2.4B Settlement in Actos Cases


In one of the largest product-liability settlements in the pharmaceutical industry, Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits claiming Takeda’s diabetes drug Actos caused bladder cancer.

About 9,000 bladder cancer claims are pending against Takeda, the New York Times reports. Takeda said the settlement would resolve most of the lawsuits involving Actos (pioglitazone). Takeda will take a $2.7 billion charge against earnings to cover the settlement and litigation costs for the remaining cases. More than 3,500 lawsuits brought over Actos have been consolidated before U.S. District Judge Rebecca Doherty in Lafayette, Louisiana, for pretrial discovery, court dockets indicate. Another 4,500 cases have been filed in state courts in Illinois, West Virginia, California, and Pennsylvania. More Takeda Announces $2.4 Billion Settlement in Actos Bladder Cancer Cases

After Years of Unfixed Problems, FDA Says Medtronic Must Stop Selling Synchromed Drug Pumps

Medtronic Must Stop Selling Synchromed Drug Pumps

Medtronic Must Stop Selling Synchromed Drug Pumps


Medtronic must stop selling the majority of its implantable drug pumps due to years of unfixed problems, the U.S. Food and Drug Administration (FDA) said. Star Tribune reports that the agency has filed a court order stating that Medtronic must stop distributing and producing its Synchromed II drug pumps. The devices are surgically implanted to delivery a drug solution in the area surrounding the spine in patients with cancer, chronic pain and severe muscle spasms. The pumps were recalled because they may lose battery power and fail, causing harm to patients. The devices were also problematic in cases where they delivered the wrong amount of medication. Even though Medtronic has been aware of problems since 2006, they have failed to act; this lack of compliance has prompted to the FDA more aggressively assert its authority. More After Years of Unfixed Problems, FDA Says Medtronic Must Stop Selling Synchromed Drug Pumps

In New York City, an Average of One Passerby per Month is Injured in a Construction Accident

A new Department of Buildings analysis shows that in New York City, an average of one passerby per month is injured in a construction accident.

An average of one passerby per month is injured.


A new Department of Buildings analysis shows that in New York City, an average of one passerby per month is injured in a construction accident.

A Wall Street Journal investigation which focused on passerby injuries, rather than injuries to both construction workers and passersby, found that 96 construction accidents involving passersby occurred between 2008 and 2014, resulting in 155 injuries. More than three-quarters of the accidents happened in Manhattan, according to The Real Deal. More In New York City, an Average of One Passerby per Month is Injured in a Construction Accident